444 related articles for article (PubMed ID: 10895128)
1. Bladder-sparing treatment of invasive bladder cancer.
Rivera I; Wajsman Z
Cancer Control; 2000; 7(4):340-6. PubMed ID: 10895128
[TBL] [Abstract][Full Text] [Related]
2. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.
Koga F; Kihara K
Int J Urol; 2012 May; 19(5):388-401. PubMed ID: 22409269
[TBL] [Abstract][Full Text] [Related]
3. Bladder-sparing approaches to invasive disease.
Efstathiou JA; Zietman AL; Kaufman DS; Heney NM; Coen JJ; Shipley WU
World J Urol; 2006 Nov; 24(5):517-29. PubMed ID: 17082940
[TBL] [Abstract][Full Text] [Related]
4. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
[TBL] [Abstract][Full Text] [Related]
5. Treatment of muscle-invasive bladder cancer: A systematic review.
Chou R; Selph SS; Buckley DI; Gustafson KS; Griffin JC; Grusing SE; Gore JL
Cancer; 2016 Mar; 122(6):842-51. PubMed ID: 26773572
[TBL] [Abstract][Full Text] [Related]
6. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
[TBL] [Abstract][Full Text] [Related]
7. Bladder sparing surgery in high-grade bladder cancer.
Yakovlev PG; Klyushin DA; Vereshchako RI
Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
[TBL] [Abstract][Full Text] [Related]
8. Challenges in the treatment of bladder cancer.
Kaufman DS
Ann Oncol; 2006 May; 17 Suppl 5():v106-12. PubMed ID: 16807436
[TBL] [Abstract][Full Text] [Related]
9. Organ-sparing strategies in the management of invasive bladder cancer.
Yafi FA; Cury FL; Kassouf W
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1765-75. PubMed ID: 19954288
[TBL] [Abstract][Full Text] [Related]
10. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery.
Merseburger AS; Kuczyk MA
Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631
[TBL] [Abstract][Full Text] [Related]
11. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU
J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067
[TBL] [Abstract][Full Text] [Related]
12. Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?
Kuczyk M; Turkeri L; Hammerer P; Ravery V;
Eur Urol; 2003 Jul; 44(1):57-64. PubMed ID: 12814676
[TBL] [Abstract][Full Text] [Related]
13. Multimodality bladder preservation therapy for muscle-invasive bladder tumors.
Fernando SA; Sandler HM
Semin Oncol; 2007 Apr; 34(2):129-34. PubMed ID: 17382796
[TBL] [Abstract][Full Text] [Related]
14. The current status of bladder preservation in the treatment of muscle invasive bladder cancer.
Kim HL; Steinberg GD
J Urol; 2000 Sep; 164(3 Pt 1):627-32. PubMed ID: 10953112
[TBL] [Abstract][Full Text] [Related]
15. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.
Tanabe K; Yoshida S; Koga F; Inoue M; Kobayashi S; Ishioka J; Tamura T; Sugawara E; Saito K; Akashi T; Fujii Y; Kihara K
Clin Genitourin Cancer; 2015 Aug; 13(4):e243-e251. PubMed ID: 25936588
[TBL] [Abstract][Full Text] [Related]
16. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
[TBL] [Abstract][Full Text] [Related]
17. [New developments in the treatment of muscle-invasive bladder cancer].
Kerst JM; Pos FJ; Visser O; Horenblas S
Ned Tijdschr Geneeskd; 2008 Jan; 152(4):187-92. PubMed ID: 18320942
[TBL] [Abstract][Full Text] [Related]
18. Organ preservation for muscle-invasive bladder cancer by transurethral resection.
Leibovici D; Kassouf W; Pisters LL; Pettaway CA; Wu X; Dinney CP; Grossman HB
Urology; 2007 Sep; 70(3):473-6. PubMed ID: 17905099
[TBL] [Abstract][Full Text] [Related]
19. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
Pansadoro V; Emiliozzi P
Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
[TBL] [Abstract][Full Text] [Related]
20. Organ preservation in muscle-invasive bladder cancer.
Fernando SA; Sandler HM
Oncology (Williston Park); 2005 Mar; 19(3):334-9; discussion 339-40, 345, 349, 350-3. PubMed ID: 15828550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
